The prognostic significance of single hormone receptor positive metastatic breast cancer: An analysis of three randomised phase III trials of aromatase inhibitors-Reference-Cited by-同舟云学术

The prognostic significance of single hormone receptor positive metastatic breast cancer: An analysis of three randomised phase III trials of aromatase inhibitors

Published:2009-12 Issue:6 Volume:18 Page:351-355
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Stuart-Harris R.,Shadbolt B.,Palmqvist C.,Chaudri Ross H.A.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference24 articles.

1. Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status;Collett;J Clin Pathol,1996

2. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a southwest oncology group study;Elledge;Int J Cancer,2000

3. Time to stop progesterone receptor testing in breast cancer management;Olivotto;J Clin Oncol,2004

4. The value of estrogen and progesterone receptors in the treatment of breast cancer;Osborne;Cancer,1980

5. The role of progesterone receptors in the management of advanced breast cancer;Bloom;Cancer,1980

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncotype DX in Breast Cancer Management: Insights and Outcomes From the United Arab Emirates;Cureus;2024-03-20

2. The Current and Future Roles of Precision Oncology in Advanced Breast Cancer;Journal of Nuclear Medicine;2024-02-01

3. Expression Patterns and Relevance of FN3K, Nrf2, and NQO1 in Breast Cancers;EURASIAN J MED ONCOL;2024

4. Treatment options for patients with hormone receptor-positive, HER2-negative advanced-stage breast cancer: maintaining cyclin-dependent kinase 4/6 inhibitors beyond progression;Frontiers in Oncology;2023-10-04

5. Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study;Cancers;2023-06-30